Screen | Randomisation | Follow-up period | ||||
Visiting period (weeks) | T0 | T1 | T2 | T3 | T4 | |
−4 | 0 | 24±4 | 48±4 | 72±4 | 96±4 | |
Informed consent | × | |||||
Inclusion and exclusion criteria | × | |||||
Demographic data | × | |||||
Medical history | × | |||||
Information of haemodialysis | × | × | × | × | × | |
Laboratory examination | × | × | × | × | × | |
Cognitive function | × | × | × | |||
Imageological examination | × | × | ||||
Drug administration | × | × | × | × | × | |
Adverse event | × | × | × | × | × | × |